GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Marpai Inc (NAS:MRAI) » Definitions » Beneish M-Score

Marpai (Marpai) Beneish M-Score : -4.12 (As of Apr. 26, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Marpai Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -4.12 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Marpai's Beneish M-Score or its related term are showing as below:

MRAI' s Beneish M-Score Range Over the Past 10 Years
Min: -4.12   Med: -1.56   Max: 1.01
Current: -4.12

During the past 5 years, the highest Beneish M-Score of Marpai was 1.01. The lowest was -4.12. And the median was -1.56.


Marpai Beneish M-Score Historical Data

The historical data trend for Marpai's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marpai Beneish M-Score Chart

Marpai Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
- - - 1.01 -4.12

Marpai Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.01 4.71 17.80 0.60 -4.12

Competitive Comparison of Marpai's Beneish M-Score

For the Healthcare Plans subindustry, Marpai's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Marpai's Beneish M-Score Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Marpai's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Marpai's Beneish M-Score falls into.



Marpai Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Marpai for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9732+0.528 * 0.8516+0.404 * 1.0134+0.892 * 1.5264+0.115 * 0.6773
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.8769+4.679 * -0.374444-0.327 * 1.7474
=-4.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was $2.70 Mil.
Revenue was 8.707 + 8.729 + 10.047 + 9.672 = $37.16 Mil.
Gross Profit was 2.998 + 3.038 + 3.617 + 3.263 = $12.92 Mil.
Total Current Assets was $17.09 Mil.
Total Assets was $31.68 Mil.
Property, Plant and Equipment(Net PPE) was $2.98 Mil.
Depreciation, Depletion and Amortization(DDA) was $5.40 Mil.
Selling, General, & Admin. Expense(SGA) was $25.77 Mil.
Total Current Liabilities was $20.84 Mil.
Long-Term Debt & Capital Lease Obligation was $3.68 Mil.
Net Income was -5.027 + -7.295 + -7.557 + -8.873 = $-28.75 Mil.
Non Operating Income was -0.99 + 0.11 + -0.296 + 0.035 = $-1.14 Mil.
Cash Flow from Operations was -0.425 + -6.585 + -2.199 + -6.54 = $-15.75 Mil.
Total Receivables was $1.82 Mil.
Revenue was 7.628 + 4.938 + 5.557 + 6.219 = $24.34 Mil.
Gross Profit was 2.816 + 1.313 + 1.405 + 1.672 = $7.21 Mil.
Total Current Assets was $26.54 Mil.
Total Assets was $49.95 Mil.
Property, Plant and Equipment(Net PPE) was $5.35 Mil.
Depreciation, Depletion and Amortization(DDA) was $4.14 Mil.
Selling, General, & Admin. Expense(SGA) was $19.26 Mil.
Total Current Liabilities was $17.36 Mil.
Long-Term Debt & Capital Lease Obligation was $4.77 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(2.702 / 37.155) / (1.819 / 24.342)
=0.072722 / 0.074727
=0.9732

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(7.206 / 24.342) / (12.916 / 37.155)
=0.296032 / 0.347625
=0.8516

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (17.085 + 2.984) / 31.679) / (1 - (26.538 + 5.348) / 49.95)
=0.366489 / 0.361642
=1.0134

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=37.155 / 24.342
=1.5264

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(4.137 / (4.137 + 5.348)) / (5.398 / (5.398 + 2.984))
=0.436162 / 0.643999
=0.6773

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(25.774 / 37.155) / (19.257 / 24.342)
=0.693689 / 0.791102
=0.8769

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((3.684 + 20.843) / 31.679) / ((4.772 + 17.36) / 49.95)
=0.774235 / 0.443083
=1.7474

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-28.752 - -1.141 - -15.749) / 31.679
=-0.374444

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Marpai has a M-score of -4.12 suggests that the company is unlikely to be a manipulator.


Marpai (Marpai) Business Description

Traded in Other Exchanges
N/A
Address
5701 East Hillsborough Avenue, Suite 1417, Tampa, FL, USA, 33610-5428
Marpai Inc operates as a health plan company. It uses A.I. to predict and help prevent costly events for its members, and in turn, lower its clients' health care costs. It offers a health plan services system that addresses the problems of healthcare past and enables companies to provide healthcare to employees. The company generates the majority of its revenue from the United States.
Executives
Yaron Eitan director 65 CHALLENGER ROAD, RIDGEFIELD PARK NJ 07660
Damien Lamendola director, 10 percent owner 5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33610-5428
Edmundo Gonzalez director, officer: CEO, Secretary and Director C/O SELWAY CAPITAL ACQUISITION CORP., 74 GRAND AVENUE, 2ND FLOOR, ENGLEWOOD NJ 07631
Sagiv Shiv director
Vincent Kane director 5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33131
Ronnie Brown officer: Chief Operating Officer 5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33610-5428
Mohsen Moazami director C/O ASTREA ACQUISITION CORP., 55 OCEAN LANE DRIVE, APT. 3021, KEY BISCAYNE FL 33149
Lutz Finger officer: See Remarks 5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33610
Yoram Bibring officer: Chief Financial Officer C/O SELWAY ACQUISITION CORPORATION, 66 FORD ROAD, SUITE 230, DENVILLE NJ 07834
Jane Cavalier director 5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33610-5428
Diclaudio Colleen director 456 SEATON STREET, LOS ANGELES CA 90013
Art Hoath officer: Chief Revenue Officer 5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33610-5428
Gonen Antebi director 5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33610-5428
Eli David other: See footnote (1) 5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33131